Literature DB >> 28559011

Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development.

Yosuke Ohtake1, Weimin Kong2, Rashad Hussain1, Makoto Horiuchi1, Michel L Tremblay3, Doina Ganea2, Shuxin Li4.   

Abstract

Protein tyrosine phosphatases (PTPs) play essential roles in regulating signaling events in multiple cells by tyrosine dephosphorylation. One of them, PTPσ, appears important in regulating function of plasmacytoid dendritic cells (pDC). Here we report that PTPσ deletion in knockout mice and inhibition with a selective antagonist peptide exacerbated symptoms of experimental autoimmune encephalomyelitis (EAE) by enhancing axon and myelin damage in the spinal cord. PTPσ-/- mice displayed pro-inflammatory profiles in the spinal cord and lymphoid organs following MOG peptide immunization. PTPσ deletion promoted a pro-inflammatory phenotype in conventional DCs and directly regulated differentiation of CD4+ T cells. It also facilitated infiltration of T lymphocytes, activation of macrophages in the CNS and development of EAE. Therefore, PTPσ is a key negative regulator in EAE initiation and progression, which acts by regulating functions of DCs, T cells, and other immune cells. PTPσ may become an important molecular target for treating autoimmune disorders.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cell function; Experimental autoimmune encephalomyelitis; Immune cell; Multiple sclerosis; Protein tyrosine phosphatase σ

Mesh:

Substances:

Year:  2017        PMID: 28559011      PMCID: PMC6275552          DOI: 10.1016/j.bbi.2017.05.018

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  48 in total

1.  White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.

Authors:  R A Sobel; A S Ahmed
Journal:  J Neuropathol Exp Neurol       Date:  2001-12       Impact factor: 3.685

2.  Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system.

Authors:  Karen Meathrel; Tamara Adamek; Jane Batt; Daniela Rotin; Laurie C Doering
Journal:  J Neurosci Res       Date:  2002-10-01       Impact factor: 4.164

3.  Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice.

Authors:  J A Määttä; M S Käldman; S Sakoda; A A Salmi; A E Hinkkanen
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 4.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

5.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

6.  A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions.

Authors:  Sheila Harroch; Glaucia C Furtado; Wolfgang Brueck; Jack Rosenbluth; Juan Lafaille; Moses Chao; Joseph D Buxbaum; Joseph Schlessinger
Journal:  Nat Genet       Date:  2002-09-30       Impact factor: 38.330

7.  Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.

Authors:  Anna Bunin; Vanja Sisirak; Hiyaa S Ghosh; Lucja T Grajkowska; Z Esther Hou; Michelle Miron; Cliff Yang; Michele Ceribelli; Noriko Uetani; Laurence Chaperot; Joel Plumas; Wiljan Hendriks; Michel L Tremblay; Hans Häcker; Louis M Staudt; Peter H Green; Govind Bhagat; Boris Reizis
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

8.  LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.

Authors:  Sha Mi; Bing Hu; Kyungmin Hahm; Yi Luo; Edward Sai Kam Hui; Qiuju Yuan; Wai Man Wong; Li Wang; Huanxing Su; Tak-Ho Chu; Jiasong Guo; Wenming Zhang; Kwok-Fai So; Blake Pepinsky; Zhaohui Shao; Christilyn Graff; Ellen Garber; Vincent Jung; Ed Xuekui Wu; Wutian Wu
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

Review 9.  Molecular mechanisms of scar-sourced axon growth inhibitors.

Authors:  Yosuke Ohtake; Shuxin Li
Journal:  Brain Res       Date:  2014-09-01       Impact factor: 3.252

10.  Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.

Authors:  Kazuya Kuboyama; Akihiro Fujikawa; Makoto Masumura; Ryoko Suzuki; Masahito Matsumoto; Masaharu Noda
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more
  9 in total

1.  Emerging molecular therapeutic targets for spinal cord injury.

Authors:  Shuo Wang; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Expert Opin Ther Targets       Date:  2019-09-04       Impact factor: 6.902

2.  Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination.

Authors:  Samira Ghorbani; Emily Jelinek; Rajiv Jain; Benjamin Buehner; Cenxiao Li; Brian M Lozinski; Susobhan Sarkar; Deepak K Kaushik; Yifei Dong; Thomas N Wight; Soheila Karimi-Abdolrezaee; Geert J Schenk; Eva M Strijbis; Jeroen Geurts; Ping Zhang; Chang-Chun Ling; V Wee Yong
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

Review 3.  Targeting Receptor-Type Protein Tyrosine Phosphatases with Biotherapeutics: Is Outside-in Better than Inside-Out?

Authors:  Yotis A Senis; Alastair J Barr
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

4.  Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal.

Authors:  Mattias N D Svensson; Martina Zoccheddu; Shen Yang; Gyrid Nygaard; Christian Secchi; Karen M Doody; Kamil Slowikowski; Fumitaka Mizoguchi; Frances Humby; Rebecca Hands; Eugenio Santelli; Cristiano Sacchetti; Kuninobu Wakabayashi; Dennis J Wu; Christopher Barback; Rizi Ai; Wei Wang; Gary P Sims; Piotr Mydel; Tsuyoshi Kasama; David L Boyle; Francesco Galimi; David Vera; Michel L Tremblay; Soumya Raychaudhuri; Michael B Brenner; Gary S Firestein; Costantino Pitzalis; Anna-Karin H Ekwall; Stephanie M Stanford; Nunzio Bottini
Journal:  Sci Adv       Date:  2020-06-26       Impact factor: 14.136

5.  High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.

Authors:  Muntinee Lertpanprom; Atit Silsirivanit; Patcharaporn Tippayawat; Tanakorn Proungvitaya; Sittiruk Roytrakul; Siriporn Proungvitaya
Journal:  Front Public Health       Date:  2022-08-01

6.  Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis.

Authors:  Fucheng Luo; Amanda Phuong Tran; Li Xin; Chandrika Sanapala; Bradley T Lang; Jerry Silver; Yan Yang
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

Review 7.  Diverse functions of protein tyrosine phosphatase σ in the nervous and immune systems.

Authors:  Yosuke Ohtake; Atsushi Saito; Shuxin Li
Journal:  Exp Neurol       Date:  2018-01-31       Impact factor: 5.330

8.  PTPσ Knockdown in Lampreys Impairs Reticulospinal Axon Regeneration and Neuronal Survival After Spinal Cord Injury.

Authors:  William Rodemer; Guixin Zhang; Isabelle Sinitsa; Jianli Hu; Li-Qing Jin; Shuxin Li; Michael E Selzer
Journal:  Front Cell Neurosci       Date:  2020-03-19       Impact factor: 5.505

9.  LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury.

Authors:  Lan Cheng; Armin Sami; Biswarup Ghosh; Mark W Urban; Nicolette M Heinsinger; Sophia S Liang; George M Smith; Megan C Wright; Shuxin Li; Angelo C Lepore
Journal:  Neurobiol Dis       Date:  2020-10-28       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.